FibroGen Inc
(NAS:FGEN)
$
0.58
0.001 (0.17%)
Market Cap: 58.45 Mil
Enterprise Value: 48.65 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 49/100 FibroGen Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021 / 05:50PM GMT
Release Date Price:
$38.07
(-24.66%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
And good afternoon, everybody, and thank you for joining us for the second day of the 41st Annual Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst here at Cowen with my colleague, Brendan Smith. And it's a great pleasure for us to moderate the fireside chat with FibroGen.
Today, we have Enrique Conterno, who's the CEO; and Mike Tung, VP of Investor Relations and Strategy. Gentlemen, thanks so much for joining us. We appreciate it.
Enrique A. Conterno
FibroGen, Inc. - CEO & Director
Thank you very much for the invitation, Yaron.
Questions & Answers
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Absolutely. So Enrique, maybe the timing for this is good in a way, just given some of the news from yesterday, obviously, wasn't prepped that way by chance. But maybe give us a little bit of a sense related to the news flow
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot